Synthetic Retinoids for Use in RAR Mediated Conditions

Andrew Whiting (Inventor), David Chisholm (Inventor), Roy Valentine (Inventor), Iain Robert Greig (Inventor), Peter John Andrew McCaffery (Inventor), Thabat Alkhatib (Inventor)

Research output: Patent

Abstract

There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.
Original languageEnglish
Patent numberWO2017174999
IPCC07C 63/66,A61K 31/192,A61K 31/203,A61P 25/28,C07D 209/82,C07D 215/06
Priority date6/04/17
Publication statusPublished - 18 Apr 2019

Fingerprint

Retinoids

Cite this

Whiting, A., Chisholm, D., Valentine, R., Greig, I. R., McCaffery, P. J. A., & Alkhatib, T. (2019). IPC No. C07C 63/66, A61K 31/192, A61K 31/203, A61P 25/28, C07D 209/82, C07D 215/06. Synthetic Retinoids for Use in RAR Mediated Conditions. (Patent No. WO2017174999). European Patent Office.

Synthetic Retinoids for Use in RAR Mediated Conditions. / Whiting, Andrew (Inventor); Chisholm, David (Inventor); Valentine, Roy (Inventor); Greig, Iain Robert (Inventor); McCaffery, Peter John Andrew (Inventor); Alkhatib, Thabat (Inventor).

European Patent Office. IPC No.: C07C 63/66, A61K 31/192, A61K 31/203, A61P 25/28, C07D 209/82, C07D 215/06. Patent No.: WO2017174999.

Research output: Patent

Whiting, A, Chisholm, D, Valentine, R, Greig, IR, McCaffery, PJA & Alkhatib, T 2019, Synthetic Retinoids for Use in RAR Mediated Conditions, Patent No. WO2017174999, IPC No. C07C 63/66, A61K 31/192, A61K 31/203, A61P 25/28, C07D 209/82, C07D 215/06.
Whiting A, Chisholm D, Valentine R, Greig IR, McCaffery PJA, Alkhatib T, inventors. Synthetic Retinoids for Use in RAR Mediated Conditions. C07C 63/66, A61K 31/192, A61K 31/203, A61P 25/28, C07D 209/82, C07D 215/06. 2019 Apr 18.
Whiting, Andrew (Inventor) ; Chisholm, David (Inventor) ; Valentine, Roy (Inventor) ; Greig, Iain Robert (Inventor) ; McCaffery, Peter John Andrew (Inventor) ; Alkhatib, Thabat (Inventor). / Synthetic Retinoids for Use in RAR Mediated Conditions. European Patent Office. IPC No.: C07C 63/66, A61K 31/192, A61K 31/203, A61P 25/28, C07D 209/82, C07D 215/06. Patent No.: WO2017174999.
@misc{afd6bc0e7a1a423ea0b564aaa80f6669,
title = "Synthetic Retinoids for Use in RAR Mediated Conditions",
abstract = "There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.",
author = "Andrew Whiting and David Chisholm and Roy Valentine and Greig, {Iain Robert} and McCaffery, {Peter John Andrew} and Thabat Alkhatib",
year = "2019",
month = "4",
day = "18",
language = "English",
publisher = "European Patent Office",
type = "Patent",
note = "WO2017174999; C07C 63/66,A61K 31/192,A61K 31/203,A61P 25/28,C07D 209/82,C07D 215/06",

}

TY - PAT

T1 - Synthetic Retinoids for Use in RAR Mediated Conditions

AU - Whiting, Andrew

AU - Chisholm, David

AU - Valentine, Roy

AU - Greig, Iain Robert

AU - McCaffery, Peter John Andrew

AU - Alkhatib, Thabat

PY - 2019/4/18

Y1 - 2019/4/18

N2 - There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.

AB - There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.

M3 - Patent

M1 - WO2017174999

PB - European Patent Office

ER -